Feb 22, 2010 –
Shanghai, China
Health Vision Enterprise appoints Rogers Luo as National Sales Director

December 2, 2009 –
Shanghai, China
Health Vision’s targeted products have all been successfully listed in China’s National Drug Reimbursement List

October 26, 2009 –
Shanghai, China
Management buyout of Stada’s 51% share of Health Vision Enterprise Ltd to re gain 100% control

Jul 30, 2008 –
Tokyo, Japan
Health Vision Enterprise appoints Eisai China Inc. as the marketing agent for Alpha Lipon®, a company with a focus in endocrinology

Oct 28, 2007 –
Nan Jing, China
Health Vision (Nan Jing) Medicine Company Limited obtains GSP license

April 28, 2007 –
Nan Jing, China
Obtain business license for Health Vision (Nan Jing) Medicine company, a wholly foreign owned enterprise allowing importation, logistic distribution and licensing-in products

March 24, 2007 –
Shanghai, China
Health Vision Enterprise executes exclusive marketing agreement with Shanghai RAAS for their innovative haemostatic product, FibinGluRAAS®, a dual syringe containing fibrinogen and thrombin


"Peak performers want more than merely to win. They see all the way to the championship. Health Vision has a long-range goal that inspires commitment. It really is win-win when partnering with Health Vision."


~ Daniel Goelich, Area Ops Manager ITB
MEDA Pharma GmbH & Co KG,
Germany ~



"Our aim is to bring innovative pharma products to China's hospitals and doctors and establish them as leading brands."

~ Zona Yim, Managing Director,
Health Vision Enterprise ~